These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 832516)
61. Changes in blood thiamphenicol levels in renal failure. Traeger J; Moskovchenko J; Monier JC; Zech P Postgrad Med J; 1974 Oct; 50 Suppl 5():39-40. PubMed ID: 4470816 [No Abstract] [Full Text] [Related]
62. [Magnesemia in patients with renal insufficiency in the period of time proceding the hemodialysis therapy (author's transl)]. Revúsová V; Gratzlová J; Reznicek J; Pribylincová V; Boroösvá E; Zvara V Cas Lek Cesk; 1976 Dec; 115(52):1608-11. PubMed ID: 1017007 [No Abstract] [Full Text] [Related]
63. Plasma concentrations of astemizole in patients with terminal renal insufficiency, before, during and after hemodialysis. Zazgornik J; Scholz N; Heykants J; Vanden Bussche G Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):246-8. PubMed ID: 2874116 [TBL] [Abstract][Full Text] [Related]
64. Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses. Zozaya DH; Gutiérrez OL; Ocampo CL; Sumano LH J Vet Pharmacol Ther; 2008 Aug; 31(4):321-7. PubMed ID: 18638292 [TBL] [Abstract][Full Text] [Related]
65. Vancomycin clearance with high-flux dialysis membranes. Anandan JV; Touchette MA Int J Artif Organs; 1998 Mar; 21(3):131-3. PubMed ID: 9622110 [No Abstract] [Full Text] [Related]
66. Diffusion of beta-lactam antibiotics and fosfomycin to interstitial tissue fluid in rabbits. Vicente MV; Olay T; Quecedo MC; Rodríguez A Chemotherapy; 1979; 25(6):329-35. PubMed ID: 42516 [TBL] [Abstract][Full Text] [Related]
67. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752 [TBL] [Abstract][Full Text] [Related]
68. A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis. Riccobene T; Jakate A; Rank D J Clin Pharmacol; 2014 Jul; 54(7):742-52. PubMed ID: 24431097 [TBL] [Abstract][Full Text] [Related]
69. [Changes in serum osmolality during hemodialysis of patients with chronic renal insufficiency (author's transl)]. Loutocký A; Lachmanová J; Tomásek R; Horký K Cas Lek Cesk; 1977 Feb; 116(6):177-81. PubMed ID: 851974 [No Abstract] [Full Text] [Related]
70. [Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis]. Kawamura J; Okabe T; Yamashita A; Sawanishi K; Katõ T Hinyokika Kiyo; 1971 Mar; 17(3):157-86. PubMed ID: 5103947 [No Abstract] [Full Text] [Related]
71. [Pharmacokinetics of trometamol-fosfomycin in patients with renal insufficiency]. Fillastre JP; Leroy A; Josse S; Moulin B Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):728-30. PubMed ID: 3054756 [TBL] [Abstract][Full Text] [Related]
72. [Antibiotic dosage in renal insufficiency]. Brass H; Heintz R Dtsch Med Wochenschr; 1968 Jan; 93(4):177-80. PubMed ID: 5640352 [No Abstract] [Full Text] [Related]
73. Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration. Aramayona JJ; Bregante MA; Solans C; Rueda S; Fraile LJ; Garcia MA Vet Res; 1997; 28(6):581-8. PubMed ID: 9428152 [TBL] [Abstract][Full Text] [Related]
74. [Levels of plasma pseudocholinesterase in chronic renal insufficiency patients and hemodialysis]. Vila P; Silla I; Porta J; Fontestad A; Montero Benzo R Rev Esp Anestesiol Reanim; 1987; 34(6):431-7. PubMed ID: 3423372 [No Abstract] [Full Text] [Related]
75. [Tolerance to fosfomycin using greatly elevated doses in the treatment of urinary septicemia in renal insufficiency]. Neuman M Minerva Med; 1978 Dec; 69(59):4105-6. PubMed ID: 740306 [No Abstract] [Full Text] [Related]
76. Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin. Pfeifer G; Frenkel C; Entzian W Int J Clin Pharmacol Res; 1985; 5(3):171-4. PubMed ID: 4018950 [TBL] [Abstract][Full Text] [Related]
77. [Clinical experience with fosfomycin-sodium in purulent osteomyelitis (author's transl)]. Yoh K; Hatanaka I; Nakano K Jpn J Antibiot; 1981 Oct; 34(10):1387-94. PubMed ID: 7334575 [No Abstract] [Full Text] [Related]
78. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis. Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656 [TBL] [Abstract][Full Text] [Related]
79. [Functional, histological, ultrastructural and biochemical study of rat kidney treated with fosfomycin and gentamycin, administered separately or together]. Viotte G; Morin JP; Bendirdjian JP; Godin M; Fillastre JP C R Seances Soc Biol Fil; 1980; 173(6):1152-6. PubMed ID: 6104535 [TBL] [Abstract][Full Text] [Related]
80. Treatment of respiratory infections with fosfomycin. Menéndez A; Tutor A; Sousa AS Chemotherapy; 1977; 23 Suppl 1():348-57. PubMed ID: 832536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]